| Literature DB >> 31827617 |
Antero Fernandes1,2, Jéssica Rodrigues3, Patrícia Lages4, Sara Lança2, Paula Mendes5, Luís Antunes3, Carla Salomé Santos6, Clara Castro3,7, Rafael S Costa8,9, Carlos Silva Lopes10, Paulo Matos da Costa4, Lúcio Lara Santos1,6,10.
Abstract
BACKGROUND: Postoperative pulmonary complications (PPCs) contribute significantly to overall postoperative morbidity and mortality. In abdominal surgery, PPCs remain frequent. The study aimed to analyze the profile and outcomes of PPCs in patients submitted to abdominal surgery and admitted in a Portuguese polyvalent intensive care unit.Entities:
Keywords: Abdominal surgery; Acute respiratory failure; Mechanical ventilation; Polyvalent intensive care unit; Postoperative pulmonary complications; Risk score
Year: 2019 PMID: 31827617 PMCID: PMC6889593 DOI: 10.1186/s13037-019-0221-5
Source DB: PubMed Journal: Patient Saf Surg ISSN: 1754-9493
Severity criteria on admission, PICU Length of stay and mortality of patients undergoing AS
| Admitted patients | 60 cases |
|---|---|
PICU hospitalization time in days (median, min-max) APACHE II (mean ± standard deviation) SAPS II (mean ± standard deviation) | 6.31 days [0.8–21] 22.8 ± 8.1points 50.7 ± 17.9points |
| PICU Mortality rate (n, %) | 21.7% (13 patients) |
| Hospital mortality rate (n, %) | 36.7% (22 patients) |
| SMR for SAPS II (median, min-max) | 0.68 points [0.53–0.74] |
| Readmission rate < 48 h (%) | 0.9% |
| VAP, number of episodes/1000 days of IT (median, min-max) | 8.7 [7.1–10.3] |
APACHE Acute Physiology, Age, Chronic Health Evaluation, AS abdominal surgery, IT tracheal intubation, PICU polyvalent intensive care unit, PPCs Postoperative pulmonary complications, SAPS Simplified Acute Physiology Score, SMR Standardized Mortality Rate, VAP ventilator-associated pneumonia
AS etiology in patients with PPCs
| Etiology | Patients | Emergency surgery (n, %) | Elective surgery (n, %) | ||
|---|---|---|---|---|---|
| ≤48 h | > 48 h | ≤48 h | > 48 h | ||
| Peritonitis | 11 (18.3) | 9 (15.0) | 2 (3.3) | – | – |
| Colorectal cancer | 9 (15.0) | – | 2 (3.3) | 7 (11.7) | – |
| Mesenteric ischemia | 8 (13.3) | 1 (1.7) | 7 (11.7) | – | – |
| Cholangiocarcinoma | 5 (8.3) | – | – | 3 (5.0) | 2 (3.3) |
| Bowel obstruction | 4 (6.7) | 3 (5.0) | 1 (1.7) | – | – |
| Abdominal trauma | 3 (5.0) | 2 (3.3) | 1 (1.7) | – | – |
| Acute Pancreatitis | 3 (5.0) | – | 3 (5.0) | – | – |
| Gastric cancer | 5 (8.3) | – | – | 4 (6.7) | 1 (1.7) |
| Esophageal cancer | 5 (8.3) | – | – | 5 (8.3) | – |
| Cholecystitis | 5 (8.3) | 2 (3.3) | 3 (5.0) | – | – |
| Diverticulitis | 1 (1.7) | – | – | – | 1 (1.7) |
| Abdominal aortic aneurysm | 1 (1.7) | – | – | – | 1 (1.7) |
Fig. 1Postoperative pulmonary complication in the first 48 h and after 48 h
Potential perioperative risk factors and PPCS, Mechanical Ventilation and 30-day mortality
| Variable | n | PPC | Mechanical Ventilation | 30-Day Mortality | |
|---|---|---|---|---|---|
| ≤ 48 h | > 48 h | ||||
| OR (95% C.I.)a | OR (95% C.I.)a | OR (95% C.I.)a | OR (95% C.I.)a | ||
| Sex | |||||
| M | 45 | 1 | 1 | 1 | 1 |
| F | 15 | 0.48 (0.15–1.58) | 3.50 (0.87–14.11) | 0.59 (0.15–2.35) | 2.31 (0.62–8.64) |
| NMBD | |||||
| No | 43 | 1 | 1 | 1 | 1 |
| Yes | 17 | 0.67 (0.21–2.08) | ** | 2.81 (0.78–10.12) | |
| Age | 60 | 1.05 (0.98–1.13) | 0.95 (0.89–1.03) | 1.01 (0.93–1.10) | 1.05 (0.97–1.15) |
| ASA | |||||
| 1 | 18 | 1 | 1 | 1 | 1 |
| 2 | 17 | 0.37 (0.07–1.80) | 0.56 (0.14–2.21) | 0.94 (0.05–16.35) | 1.09 (0.27–4.41) |
| 3 | 13 | 0.32 (0.06–1.70) | 0.31 (0.07–1.38) | 0.13 (0.01–1.37) | 0.17 (0.02–1.60) |
| 4 | 12 | 2.50 (0.41–15.23) | ** | ||
| ARISCAT | |||||
| Low risk < 26 | 14 | 1 | 1 | 1 | 1 |
| Intermediate Risk 26–44 | 16 | 1.65 (0.37–7.37) | 0.21 (0.04–1.29) | 0.72 (0.10–5.09) | 1.50 (0.32–6.99) |
| High risk > 45 | 30 | 0.98 (0.27–3.53) | 0.55 (0.10–3.06) | 0.28 (0.05–1.47) | |
| Respiratory Infection | |||||
| No | 50 | 1 | 1 | 1 | 1 |
| Yes | 10 | 1.00 (0.25–4.00) | 1.69 (0.39–7.31) | 2.54 (0.29–22.27) | 1.71 (0.38–7.84) |
| Anemia | |||||
| No | 30 | 1 | 1 | 1 | 1 |
| Yes | 30 | 0.76 (0.27–2.13) | 2.33 (0.81–6.73) | 1.00 (0.28–3.54) | 1.22 (0.36–4.17) |
| Incision Type | |||||
| Bilateral subcostal | 21 | 1 | 1 | 1 | 1 |
| Median | 39 | 0.13 (0.02–1.07) | 0.55 (0.16–1.91) | ||
| LPT vs. LPC | |||||
| LPC (Laparoscopy) | 19 | 1 | 1 | 1 | 1 |
| LPT (Laparotomy) | 41 | 1.14 (0.38–3.43) | 1.14 (0.38–3.43) | 1.73 (0.47–6.40) | 0.45 (0.13–1.58) |
| Surgery Duration | |||||
| < 180 min | 42 | 1 | 1 | 1 | 1 |
| > 180 min | 18 | 3.18 (0.90–11.28) | 2.50 (0.49–12.79) | 2.50 (0.70–8.92) | |
| Smokers | |||||
| No | 35 | 1 | 1 | 1 | 1 |
| Yes | 25 | 1.33 (0.46–3.83) | 0.75 (0.26–2.14) | 1.00 (0.28–3.61) | 0.55 (0.15–2.04) |
| BMI | |||||
| < 18 | 12 | 1 | 1 | 1 | 1 |
| 18–25 | 20 | 0.78 (0.15–3.93) | 1.40 (0.33–5.93) | ** | 0.75 (0.14–4.13) |
| 25–30 | 16 | 0.56 (0.11–2.90) | 2.33 (0.51–10.78) | ** | 1.36 (0.25–7.32) |
| 30–35 | 12 | ** | 0.27 (0.02–3.09) | ||
| COPD/Asthma History | |||||
| No | 42 | 1 | 1 | 1 | 1 |
| Yes | 18 | 0.56 (0.18–1.70) | 2.15 (0.65–7.11) | 1.63 (0.45–5.92) | |
| POSA | |||||
| ≤ 35 g/L | 8 | 5.55 (0.64–48.41) | 0.63 (0.14–2.79) | 1.88 (0.21–16.92) | |
| > 35 g/l | 52 | 1 | 1 | 1 | 1 |
| Lactate | |||||
| < 4 mmol/l | 14 | 1 | 1 | 1 | 1 |
| > 4 mmol/l | 46 | 0.52 (0.14–1.90) | 1.17 (0.35–3.92) | ** | 0.38 (0.10–1.44) |
| PREOP Abnormal Arterial blood gases | |||||
| No | 20 | 1 | 1 | 1 | 1 |
| Yes | 40 | 1.57 (0.43–5.77) | 0.49 (0.14–1.74) | ||
| Pa02 ≤ 50 ≥ 60 Moderate - Severe ARF | |||||
| No | 25 | 1 | 1 | 1 | 1 |
| Yes | 35 | 2.36 (0.82–6.83) | 0.41 (0.14–1.23) | 1.53 (0.43–5.44) | 1.82 (0.49–6.74) |
| Pa02/FiO2 | |||||
| < 100 | 21 | 0.83 (0.28–2.45) | 1.13 (0.38–3.35) | 1.80 (0.43–7.53) | ** |
| 101–300 | 39 | 1 | 1 | 1 | 1 |
| PREOP Abnormal Chest radiography | |||||
| No | 36 | 1 | 1 | 1 | 1 |
| Yes | 24 | 3.00 (0.97–9.30) | 0.37 (0.13–1.09) | 4.23 (0.84–21.40) | 2.06 (0.59–7.13) |
ASA PS American Society of Anesthesiologists physical status, BMI body mass index, COPD Chronic Obstructive Pulmonary Disease, FiO Inspiratory oxygen fraction, LPC Laparoscopy, LPT Laparotomy, NMBD Neuromuscular blocking drugs, PaO arterial oxygen pressure, PREOP preoperative period, POSA preoperative serum albumin. a Unadjusted (Univariable Model);** No cases in at least one of the groups; Bold - significant values.
PPCs, 30-day mortality and Severity Indices
| Patients undergoing AS | Patients number (%) | 30-day mortality | APACHE II (mean) | SAPS II (mean) |
|---|---|---|---|---|
| OP | 60 (100) | 21.7% | 22.8 ± 8.1* | 50.7 ± 17.9* |
| PPCs ≤48 h | 36 (60) | 27.8% (10 patients) | 23.0 ± 6.5** | 49.0 ± 17.3** |
| PPCs > 48 h | 24 (40) | 12.5% (3 patients) | 22.5 ± 10.2** | 53.2 ± 18.9** |
APACHE Acute Physiology, Age, Chronic Health Evaluation, AS abdominal surgery, OP operated patients, PPCs postoperative pulmonary complications, SAPS Simplified Acute Physiology Score; * (APACHE: p = 0.829; SAPS: p = 0.378). ** statistically not significant